Related Experiment Videos
Investigation and management of symptomatic hyperprolactinaemia
Summary
Hyperprolactinemia, often causing infertility, amenorrhea, and galactorrhea, can be effectively treated with prolactin suppression using bromoergocryptine, restoring fertility in most patients.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Neuroendocrinology
Background:
- Hyperprolactinemia is associated with infertility, amenorrhea, and galactorrhea.
- Pituitary tumors, including microadenomas, can cause hyperprolactinemia.
- Elevated prolactin levels can disrupt reproductive hormone secretion.
Purpose of the Study:
- To investigate the effects of hyperprolactinemia on gonadotropin secretion.
- To evaluate the efficacy of prolactin suppression in restoring fertility.
- To assess the impact of hyperprolactinemia on estrogen feedback mechanisms.
Main Methods:
- Investigated 19 patients with hyperprolactinemia (15 infertile, 4 not desiring fertility).
- Measured prolactin, LH, and estrogen levels before and during bromoergocryptine therapy.
- Utilized TRH, chlorpromazine, LRH, and estrogen provocation tests.
Main Results:
- Bromoergocryptine effectively lowered prolactin levels.
- Hyperprolactinemia impaired estrogen's positive and negative feedback on LH secretion.
- Prolactin suppression normalized estrogen excretion and improved LH response to estrogen provocation.
- All 15 patients desiring fertility achieved pregnancy, with 9 successful term deliveries.
Conclusions:
- Hyperprolactinemia causes significant disruptions in the hypothalamic-pituitary-gonadal axis.
- Prolactin suppression is a highly effective treatment for infertility associated with hyperprolactinemia.
- Restoration of normal estrogen feedback is a key outcome of successful prolactin suppression.